# Yingjiexin Medical

> Chinese manufacturer of precision injection pens and self-administered drug-delivery systems.

## Why it is interesting

About $30M USD-equivalent Series B financing disclosed November 2 to expand injection pens and delivery devices for biologics and GLP-1 medicines.

## Profile

- **Latest funding:** Series B (November 2 disclosure) — About $30 million (USD equivalent) (November 2, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $30M
- **Stage:** series-b
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-02
- **Latest funding investors:** CICC Capital, Zhuhai Science and Technology Industry Group, Cornerstone Capital, Qiming Venture Partners

## Funding history

- Series B (November 2 disclosure) · About $30 million (USD equivalent) · November 2, 2026
  Source: https://www.chinaventure.com.cn/news/111-20261102-393863.html

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 2, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/yingjiexin-medical